Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Advances in the Management of Ulcerative Colitis (UC)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
Research in Ulcerative Colitis (UC) 2024
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Brazil, India, Mexico, Saudi Arabia, Taiwan, Turkey
Research in Ulcerative Colitis (UC) 2024
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Research Oncology USA
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)
Release Date:
Partner: American College of Emergency Physicians (ACEP)
Review Process: Expert Review Panel
Quality Improvement Internal Medicine USA
HER2 Expression in Urothelial Carcinoma (UC)
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Hospital Benin, Congo, The Democratic Republic
Title
Grant Type
Focus Area
Country
Application Due Date
Improving the Care of Persons Living with Metastatic Breast Cancer
Release Date:
Partner: Rethink Breast Cancer
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Addressing knowledge and practice gaps in changing paradigms of dermatological inflammatory conditions
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Education Inflammation & Immunology Canada
Improving Advanced Prostate Cancer Management in Latin America
Release Date:
Partner: Prostate Cancer Foundation
Review Process: Expert Review Panel
Education Oncology Argentina, Brazil, Chile, Colombia, Mexico
Investigating the Value of Using Patient-Reported Outcomes in Oncology Patient Care
Release Date:
Partner: The PROTEUS Consortium
Review Process: Expert Review Panel
Research Oncology USA
Addressing Knowledge Gaps in Ulcerative Colitis (UC) Care
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
2024 Inflammatory Bowel Disease (IBD) Fellowship – United States
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Improving the care and outcomes of residents of Canada living with metastatic NSCLC
Release Date:
Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung Association
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Improving the Equity and Quality of Cancer Care in Colombia
Release Date:
Partner: The Colombian Association of Oncology and Hematology (ACHO)
Review Process: Expert Review Panel
Translation: Spanish (link)
Quality Improvement Oncology Colombia
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
Release Date:
Review Process: Pfizer Internal
Education Hospital All
IBD QORUS HEALTH EQUITY REQUEST FOR APPLICATIONS (RFA)
Release Date:
Partner: Crohn's & Colitis Foundation
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology USA